CGI entered into a material transfer agreement with the University of Iowa Research Foundation, whereby CGI received specimens useful to studies evaluating the FHACT™ assay in cervical liquid biopsy specimens. Study data is analyzed jointly. CGI also entered into a biological transfer agreement with the University of Iowa for the development and validation of molecular tests, such as MatBA®-DLBCL, to improve the diagnosis, prognosis and management of diffuse large B-cell lymphoma (DLBCL).